159 related articles for article (PubMed ID: 38520515)
1. "Dirty Dry Eye"- A waste volume analysis from topical therapy in keratoconjunctivitis sicca.
Schilcher AV; Roth M; Steindor FA; Helweh R; Geerling G
Graefes Arch Clin Exp Ophthalmol; 2024 Mar; ():. PubMed ID: 38520515
[TBL] [Abstract][Full Text] [Related]
2. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
[TBL] [Abstract][Full Text] [Related]
3. Burden of dry eye disease in Germany: a retrospective observational study using German claims data.
Siffel C; Hennies N; Joseph C; Lascano V; Horvat P; Scheider M; Ganzera F
Acta Ophthalmol; 2020 Jun; 98(4):e504-e512. PubMed ID: 31736282
[TBL] [Abstract][Full Text] [Related]
4. [Use of resources in cataract surgery-More waste is (not) always possible].
Wirbelauer C; Geerling G
Ophthalmologie; 2022 Jun; 119(6):561-566. PubMed ID: 35467102
[TBL] [Abstract][Full Text] [Related]
5. Animal models of dry eye: Their strengths and limitations for studying human dry eye disease.
Chang YA; Wu YY; Lin CT; Kawasumi M; Wu CH; Kao SY; Yang YP; Hsu CC; Hung KF; Sun YC
J Chin Med Assoc; 2021 May; 84(5):459-464. PubMed ID: 33871392
[TBL] [Abstract][Full Text] [Related]
6. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
Sheppard J; Shen Lee B; Periman LM
Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
[TBL] [Abstract][Full Text] [Related]
7. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
8. Rethinking dry eye disease: a perspective on clinical implications.
Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
[TBL] [Abstract][Full Text] [Related]
9. Trends in Topical Prescriptional Therapy for Old Patients With Dry Eye Disease in Six Major Areas of China: 2013-2019.
Yu Z; Wu X; Zhu J; Jin J; Zhao Y; Yu L
Front Pharmacol; 2021; 12():690640. PubMed ID: 34447308
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial.
Rao AT; Gupta A; Chauhan T; Basu S; Batra N; Sharma N; Sangwan VS; Gupta V; Mukherjee S
BMC Ophthalmol; 2023 Mar; 23(1):121. PubMed ID: 36973703
[TBL] [Abstract][Full Text] [Related]
11. Corneal Epithelial Thickness Changes After Topical Treatment of Dry Eye Disease in Primary Sjögren Syndrome.
Loureiro T; Rodrigues-Barros S; Carreira AR; Gouveia-Moraes F; Carreira P; Vide Escada A; Campos P; Machado I; Campos N; Ambrosio R; Archer TJ; Reinstein DZ
Clin Ophthalmol; 2023; 17():993-1005. PubMed ID: 37035513
[TBL] [Abstract][Full Text] [Related]
12. Effect of Withdrawing Chronic Topical Immune Modulating Treatment on Schirmer Tear Test Values in Dogs with Dry Eye Disease: Relevance to Dry Eye Studies.
Park SA; Good KL; Thomasy SM; Kass PH; Murphy CJ
J Ocul Pharmacol Ther; 2021 Sep; 37(7):394-398. PubMed ID: 34232790
[No Abstract] [Full Text] [Related]
13. Intravitreal Injections: Improving Sustainability by Reducing Clinical Waste.
Birtel J; Hammer M; Feltgen N; Pauleikhoff L; Ong AY; Geerling G; Spitzer MS; Charbel Issa P
Klin Monbl Augenheilkd; 2024 Apr; ():. PubMed ID: 38574679
[TBL] [Abstract][Full Text] [Related]
14. Preliminary report of improved sleep quality in patients with dry eye disease after initiation of topical therapy.
Ayaki M; Toda I; Tachi N; Negishi K; Tsubota K
Neuropsychiatr Dis Treat; 2016; 12():329-37. PubMed ID: 26937189
[TBL] [Abstract][Full Text] [Related]
15. Corneal permeability changes in dry eye disease: an observational study.
Fujitani K; Gadaria N; Lee KI; Barry B; Asbell P
BMC Ophthalmol; 2016 May; 16(1):53. PubMed ID: 27177442
[TBL] [Abstract][Full Text] [Related]
16. Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.
Verjee MA; Brissette AR; Starr CE
Ophthalmol Ther; 2020 Dec; 9(4):877-888. PubMed ID: 33090327
[TBL] [Abstract][Full Text] [Related]
17. Exploring greenhouse gas emissions pathways and stakeholder perspectives: In search of circular economy policy innovation for waste paper management and carbon neutrality in Hong Kong.
Chen P; Sauerwein M; Steuer B
J Environ Manage; 2023 Sep; 341():118072. PubMed ID: 37178542
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Disease-Related Dry Eye Diseases and Their Placement Under the Revised Classification Systems: An Update.
Kılıççıoğlu A; Oncel D; Celebi ARC
Cureus; 2023 Dec; 15(12):e50276. PubMed ID: 38196419
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid in the treatment of dry eye disease.
Hynnekleiv L; Magno M; Vernhardsdottir RR; Moschowits E; Tønseth KA; Dartt DA; Vehof J; Utheim TP
Acta Ophthalmol; 2022 Dec; 100(8):844-860. PubMed ID: 35514082
[TBL] [Abstract][Full Text] [Related]
20. Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease.
de Oliveira RC; Wilson SE
Clin Ophthalmol; 2019; 13():1115-1122. PubMed ID: 31308620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
